Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: An effect mediated by Th2 cytokines

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Kvarnhammar, Anne M ^a   Rydberg, Camilla ^a   Järnkrants, Malin ^a   Eriksson, Mia ^a   Uddman, Rolf ^b   Benson, Mikael ^c   Cardell, Lars Olaf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergen specific immunotherapy; Antimicrobial peptide; Epithelium; Lipopolysaccharide; Seasonal allergic rhinitis; Th2 cytokines

Indexed keywords

HISTAMINE; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PSORIASIN; ALLERGEN; CYTOKINE; DIAGNOSTIC AGENT; IL4 PROTEIN, HUMAN; PROTEIN S 100; S100A7 PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HAY FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; NASAL BIOPSY; NASAL LAVAGE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROVOCATION TEST; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TH2 CELL; ADULT; CELL LINE; CHEMISTRY; DESENSITIZATION; DRUG EFFECT; FEMALE; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; NOSE MUCOSA; NOSE MUCUS; NOSE PROVOCATION TEST; SECRETION;

ADULT; ALLERGENS; CELL LINE; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTAMINE; HUMANS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; NASAL MUCOSA; NASAL PROVOCATION TESTS; NEUTROPHILS; RHINITIS, ALLERGIC, SEASONAL; S100 PROTEINS; TH2 CELLS; YOUNG ADULT;

EID: 84857457223     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-2     Document Type: Article

References (39)

1. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004, 322(4):1111-1122. 10.1016/j.bbrc.2004.07.096, 15336958.
2. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991, 97(4):701-712. 10.1111/1523-1747.ep12484041, 1940442.
3. West NR, Watson PH. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 2010, 29(14):2083-2092. 10.1038/onc.2009.488, 20101226.
4. Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, Mao Y, Li M, Peng A, He D, Xiao X. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 2008, 63(4):352-359. 10.1136/thx.2007.087015, 18364444.
5. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res 2007, 27(5A):3051-3058.
6. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Glaser R. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007, 133(4):253-261. 10.1007/s00432-006-0164-y, 17136347.
7. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005, 6(1):57-64. 10.1038/ni1142, 15568027.
8. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE, Thestrup-Pedersen K. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996, 107(1):5-10. 10.1111/1523-1747.ep12294284, 8752830.
9. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, et al. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 2008, 181(2):1499-1506. 2435511, 18606705.
10. Zheng Y, Niyonsaba F, Ushio H, Ikeda S, Nagaoka I, Okumura K, Ogawa H. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 2008, 124(3):357-367. 10.1111/j.1365-2567.2007.02782.x, 2440830, 18194266.
11. Bryborn M, Adner M, Cardell LO. Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir Res 2005, 6:118. 10.1186/1465-9921-6-118, 1282590, 16236163.
12. Bryborn M, Mansson A, Cardell LO, Adner M. Differentiated S100A7 expression in infected tonsils and tonsils from allergic individuals. FEMS Immunol Med Microbiol 2008, 53(3):413-420. 10.1111/j.1574-695X.2008.00444.x, 18625016.
13. Bryborn M, Hallden C, Sall T, Adner M, Cardell LO. Comprehensive evaluation of genetic variation in S100A7 suggests an association with the occurrence of allergic rhinitis. Respir Res 2008, 9:29. 10.1186/1465-9921-9-29, 2335106, 18373864.
14. Tieu DD, Peters AT, Carter RT, Suh L, Conley DB, Chandra R, Norton J, Grammer LC, Harris KE, Kato A, et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. J Allergy Clin Immunol 2010, 125(3):667-675. 10.1016/j.jaci.2009.11.045, 2841036, 20226301.
15. Richer SL, Truong-Tran AQ, Conley DB, Carter R, Vermylen D, Grammer LC, Peters AT, Chandra RK, Harris KE, Kern RC, et al. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol 2008, 22(3):228-234. 10.2500/ajr.2008.22.3162, 2810157, 18588753.
16. Mansson A, Bachar O, Adner M, Cardell LO. Nasal CpG oligodeoxynucleotide administration induces a local inflammatory response in nonallergic individuals. Allergy 2009, 64(9):1292-1300. 10.1111/j.1398-9995.2009.02012.x, 19243360.
17. Ekman AK, Fransson M, Rydberg C, Adner M, Cardell LO. Nasal Challenge with LPS Stimulates the Release of Macrophage Inflammatory Protein 1alpha. Int Arch Allergy Immunol 2009, 149(2):154-160. 10.1159/000189199, 19127073.
18. Benson M, Strannegard IL, Wennergren G, Strannegard O. Interleukin-5 and interleukin-8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 1999, 10(3):178-185.
19. Rydberg C, Mansson A, Uddman R, Riesbeck K, Cardell LO. Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas. Immunology 2009, 128(1 Suppl):e600-611. 2753959, 19740321.
20. Bogefors J, Rydberg C, Uddman R, Fransson M, Mansson A, Benson M, Adner M, Cardell LO. Nod1, Nod2 and Nalp3 receptors, new potential targets in treatment of allergic rhinitis?. Allergy 2010, 65(10):1222-1226. 10.1111/j.1398-9995.2009.02315.x, 20384614.
21. Mansson A, Cardell LO. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils. J Leukoc Biol 2009, 85(4):719-727. 10.1189/jlb.0808494, 19129482.
22. Mansson A, Adner M, Hockerfelt U, Cardell LO. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 2006, 118(4):539-548. 1782320, 16780564.
23. Mansson A, Adner M, Cardell LO. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 2006, 7:36. 10.1186/1465-9921-7-36, 1481585, 16504163.
24. Kinhult J, Adner M, Uddman R, Cardell LO. Pituitary adenylate cyclase-activating polypeptide, effects in the human nose. Clin Exp Allergy 2003, 33(7):942-949. 10.1046/j.1365-2222.2003.01721.x, 12859451.
25. Glaser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, Folster-Holst R, Proksch E, Schroder JM, Schwarz T. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009, 129(3):641-649. 10.1038/jid.2008.268, 18754038.
26. Sugiura H, Ebise H, Tazawa T, Tanaka K, Sugiura Y, Uehara M, Kikuchi K, Kimura T. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol 2005, 152(1):146-149. 10.1111/j.1365-2133.2005.06352.x, 15656815.
27. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Folster-Holst R, Proksch E, Schroder JM, Schwarz T, et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010, 130(5):1355-1364. 10.1038/jid.2009.432, 20107483.
28. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009, 124(1):37-42. 10.1016/j.jaci.2009.04.045, 2802265, 19560577.
29. Canonica GW, Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol 2009, 158(3):260-271. 10.1111/j.1365-2249.2009.04017.x, 2792821, 19765020.
30. Ricca V, Landi M, Ferrero P, Bairo A, Tazzer C, Canonica GW, Ciprandi G. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000, 105(1 Pt 1):54-57.
31. Langley SJ, Goldthorpe S, Craven M, Woodcock A, Custovic A. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects. Thorax 2005, 60(1):17-21. 10.1136/thx.2004.027839, 1747172, 15618577.
32. Micillo E, Bianco A, D'Auria D, Mazzarella G, Abbate GF. Respiratory infections and asthma. Allergy 2000, 55(Suppl 61):42-45. 10.1034/j.1398-9995.2000.00506.x, 10919505.
33. Sykes A, Johnston SL. Etiology of asthma exacerbations. J Allergy Clin Immunol 2008, 122(4):685-688. 10.1016/j.jaci.2008.08.017, 19014758.
34. Newcomb DC, Peebles RS. Bugs and asthma: a different disease?. Proc Am Thorac Soc 2009, 6(3):266-271. 10.1513/pats.200806-056RM, 2677401, 19387028.
35. Lauriello M, Muzi P, Di Rienzo L, Di Stanislao C, Tirelli GC, Bologna M. A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis. Acta Otorhinolaryngol Ital 2005, 25(5):284-291. 2639903, 16602327.
36. Reithmayer K, Meyer KC, Kleditzsch P, Tiede S, Uppalapati SK, Glaser R, Harder J, Schroder JM, Paus R. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol 2009, 161(1):78-89. 10.1111/j.1365-2133.2009.09154.x, 19775361.
37. Benson M, Strannegard IL, Wennergren G, Strannegard O. Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 1997, 8(3):143-149. 10.1111/j.1399-3038.1997.tb00168.x, 9532255.
38. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Clin Exp Allergy 2005, 35(12):1608-1614. 10.1111/j.1365-2222.2005.02381.x, 16393327.
39. Kosa L, Kovacs N, Halasz A. Interleukines in nasal lavage. Allergy 2002, 57(1):63-64.